Note 14 - Subsequent Events
|9 Months Ended|
Mar. 31, 2021
|Notes to Financial Statements|
|Subsequent Events [Text Block]||
Note 14. Subsequent Events:
On April 6, 2021, the Company acquired Asuragen, Inc. for approximately $215 million, plus contingent consideration of up to $105 million upon the achievement of certain future milestones.
On April 2, 2021, the Company invested approximately $6 million of additional funding into Eminence, increasing our percentage of outstanding equity shares to 57.42%.
The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.
Reference 1: http://www.xbrl.org/2003/role/disclosureRef